printer icon

New Zealand delegation to BIO 2019

Twenty-six New Zealand biotech companies and universities joined BIOTechNZ, New Zealand Trade and Enterprise and the Ministry of Business, Innovation and Employment as the New Zealand delegation to BIO 2019 in Philadelphia, 3-6 June.

 The attending companies were:

The New Zealand delegation would not have happened without the hard work of:

Additional thanks go to the following people for their support and hospitality:

  • Kjesten Wiig (Innovative Partnerships, MBIE)
  • James Araci (Callaghan Innovation)
  • Mike Hearn (American Chamber of Commerce in New Zealand)
  • Pip Ashford (Visit Anaheim)
  • Jacquie Palmer (Pharmaceutical solutions)
  • David Nowak (Henry Hughes IP)
  • Chris Nave (Brandon Capital)
  • Richard Stubbs and Bridget Stubbs (P3)
  • Liz Smaill, Barney Montgomery and Penny Montgomery (Optimal Clinical Trials)
BioTechNZ Our aim is to raise awareness and increase the understanding to enable our nation to embrace the best opportunities biotech offers to us daily, helping us live better, healthier and more productive lives.